What We're Reading: Page 311
Industry reads hand-picked by our editors
Jul 13, 2017
-
Kaiser Health News
Whichever way ‘repeal and replace’ blows, pharma is due for windfall
-
The New York Times
Disorderly Brexit could put patients at risk, drug industry warns
-
Los Angeles Times
Surgery for early-stage prostate cancer does not lead to longer lives, study finds
Jul 12, 2017
Jul 11, 2017
-
The New York Times
Considering the side effects of drugmakers’ money-back guarantees
-
Financial Times
Digitisation reshapes the pharma workforce
-
CNN
Research raises hopes for gonorrhea vaccine
Jul 10, 2017
Jul 07, 2017
Jul 06, 2017
Jul 05, 2017
-
The Wall Street Journal
Why big pharma is targeting China’s deadliest diseases
-
Reuters
Drugmaker Shire faces blood and guts battles on road to growth
-
Financial Times
Fears over a medical gold rush in cancer drug race
Previous
